{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:21:52Z","timestamp":1740147712088,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11739-019-02095-3","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:38:03Z","timestamp":1557344283000},"page":"1119-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endothelin-1 in hypertensive patients with ischemic heart disease"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-1261","authenticated-orcid":false,"given":"Carlo","family":"Moroni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tolone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bondanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Affricano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Cassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Gaspardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"issue":"17","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2014","unstructured":"Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J. 35(17):1101\u20131111. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht513","journal-title":"Eur Heart J."},{"issue":"8","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F (2007) Coronary microvascular dysfunction. N Engl J Med. 356(8):830\u2013840. \n                    https:\/\/doi.org\/10.1056\/NEJMra061889","journal-title":"N Engl J Med."},{"issue":"21","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","volume":"121","author":"GA Lanza","year":"2010","unstructured":"Lanza GA, Crea F (2010) Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 121(21):2317\u20132325. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.900191","journal-title":"Circulation"},{"key":"2095_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/eurheartj\/14.suppl_F.32","volume":"14","author":"JC Kaski","year":"1993","unstructured":"Kaski JC (1993) Myocardial ischaemia in the hypertensive patient\u2014the role of coronary microcirculation abnormalities. Eur Heart J. 14:32\u201337","journal-title":"Eur Heart J"},{"issue":"1","key":"2095_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.jhh.1000400","volume":"11","author":"JC Burnett","year":"1997","unstructured":"Burnett JC (1997) Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure. J Hum Hypertens. 11(1):45\u201349","journal-title":"J Hum Hypertens."},{"issue":"6","key":"2095_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/hrt.74.6.620","volume":"74","author":"JC Kaski","year":"1995","unstructured":"Kaski JC, Elliott PM, Salomone O et al (1995) Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J. 74(6):620\u2013624","journal-title":"Br Heart J."},{"issue":"10","key":"2095_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0002-9149(99)00532-9","volume":"84","author":"GA Lanza","year":"1999","unstructured":"Lanza GA, L\u00fcscher TF, Pasceri V et al (1999) Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol. 84(10):1187\u20131191","journal-title":"Am J Cardiol."},{"issue":"2","key":"2095_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0735-1097(99)00224-7","volume":"34","author":"ID Cox","year":"1999","unstructured":"Cox ID, B\u00f8tker HE, Bagger JP, Sonne HS, Kristensen BO, Kaski JC (1999) Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol. 34(2):455\u2013460","journal-title":"J Am Coll Cardiol."},{"issue":"29","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.2174\/1381612033453866","volume":"9","author":"S Taddei","year":"2003","unstructured":"Taddei S, Ghiadoni L, Virdis A, Versari D, Salvetti A (2003) Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des. 9(29):2385\u20132402","journal-title":"Curr Pharm Des."},{"issue":"5","key":"2095_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0002-8703(96)90020-4","volume":"132","author":"R Cassone","year":"1996","unstructured":"Cassone R, Moroni C, Parlapiano C, Bondanini F, Blefari T, Affricano C (1996) Endothelin-1 plasma levels in essential hypertension: increased levels with coronary artery disease. Am Heart J. 132(5):1048\u20131049","journal-title":"Am Heart J."},{"issue":"15","key":"2095_CR11","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/01.CIR.0000015606.69079.27","volume":"105","author":"C Ferri","year":"2002","unstructured":"Ferri C, Properzi G, Tomassoni G et al (2002) Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation 105(15):1768\u20131771","journal-title":"Circulation"},{"issue":"1","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/2008-7802.172549","volume":"6","author":"NE Afyouni","year":"2015","unstructured":"Afyouni NE, Halili H, Moslemi F et al (2015) Preventive role of endothelin antagonist on kidney ischemia: reperfusion injury in male and female rats. Int J Prev Med. 6(1):128. \n                    https:\/\/doi.org\/10.4103\/2008-7802.172549","journal-title":"Int J Prev Med."},{"issue":"5","key":"2095_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1053\/euhj.1997.0853","volume":"19","author":"R Willenheimer","year":"1998","unstructured":"Willenheimer R, Erhardt L, Cline C, Rydberg E, Israelsson B (1998) Exercise training in heart failure improves quality of life and exercise capacity. Eur Heart J. 19(5):774\u2013781. \n                    https:\/\/doi.org\/10.1053\/euhj.1997.0853","journal-title":"Eur Heart J."},{"issue":"4","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00004872-200404000-00013","volume":"22","author":"Y Hirai","year":"2004","unstructured":"Hirai Y, Adachi H, Fujiura Y, Hiratsuka A, Enomoto M, Imaizumi T (2004) Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study. J Hypertens. 22(4):713\u2013718","journal-title":"J Hypertens."},{"issue":"6","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1365-2362.1997.1410685.x","volume":"27","author":"C Ferri","year":"1997","unstructured":"Ferri C, De Marzio P, Desideri G et al (1997) Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularization. Eur J Clin Investig. 27(6):526\u2013532","journal-title":"Eur J Clin Investig."},{"issue":"1","key":"2095_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0167-5273(00)00256-4","volume":"74","author":"H Suzuki","year":"2000","unstructured":"Suzuki H, Takeyama Y, Matsubara H et al (2000) Plasma endothelin-1 and thrombomodulin levels in coronary sinus during right atrial pacing and percutaneous transluminal coronary angioplasty. Int J Cardiol. 74(1):15\u201323","journal-title":"Int J Cardiol."},{"issue":"1","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0167-5273(01)00394-1","volume":"79","author":"T Lubov","year":"2001","unstructured":"Lubov T, Marmor A, Gorenberg M (2001) Endothelin release: a marker for the severity of exercise-induced ischemia. Int J Cardiol. 79(1):19\u201324","journal-title":"Int J Cardiol."},{"issue":"7","key":"2095_CR18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0002-9149(97)00019-2","volume":"79","author":"F Fontana","year":"1997","unstructured":"Fontana F, Tarsi G, Boschi S, De Iasio R, Monetti N, Bugiardini R (1997) Relationship between plasma endothelin-1 levels and myocardial ischemia induced by exercise testing. Am J Cardiol. 79(7):957\u2013959","journal-title":"Am J Cardiol."},{"issue":"4","key":"2095_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0735-1097(02)02860-7","volume":"41","author":"TM Seccia","year":"2003","unstructured":"Seccia TM, Belloni AS, Kreutz R et al (2003) Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. J Am Coll Cardiol. 41(4):666\u2013673","journal-title":"J Am Coll Cardiol."},{"issue":"Suppl 3","key":"2095_CR20","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.1097\/00005344-199506263-00112","volume":"26","author":"MR Dashwood","year":"1995","unstructured":"Dashwood MR, Timm M, Muddle JR, Shah D, Tippins JR, Kaski JC (1995) [3H]bosentan binding to human coronary artery: functional correlates. J Cardiovasc Pharmacol. 26(Suppl 3):S376\u2013S379","journal-title":"J Cardiovasc Pharmacol."},{"issue":"1","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0021-9150(95)05773-0","volume":"124","author":"GT Jones","year":"1996","unstructured":"Jones GT, van Rij A, Solomon C, Thomson IA, Packer SGK (1996) Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis. 124(1):25\u201335. \n                    https:\/\/doi.org\/10.1016\/0021-9150(95)05773-0","journal-title":"Atherosclerosis."},{"issue":"4","key":"2095_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1161\/01.CIR.91.4.941","volume":"91","author":"AM Zeiher","year":"1995","unstructured":"Zeiher AM, Goebel H, Sch\u00e4chinger V, Ihling C (1995) Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. Circulation 91(4):941\u2013947. \n                    https:\/\/doi.org\/10.1161\/01.CIR.91.4.941","journal-title":"Circulation"},{"issue":"7","key":"2095_CR23","first-page":"774","volume":"24","author":"O Schillaci","year":"1997","unstructured":"Schillaci O, Moroni C, Scopinaro F et al (1997) Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. Eur J Nucl Med. 24(7):774\u2013778","journal-title":"Eur J Nucl Med."},{"issue":"6","key":"2095_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1139\/y03-009","volume":"81","author":"RM Touyz","year":"2003","unstructured":"Touyz RM, Schiffrin EL (2003) Role of endothelin in human hypertension. Can J Physiol Pharmacol. 81(6):533\u2013541. \n                    https:\/\/doi.org\/10.1139\/y03-009","journal-title":"Can J Physiol Pharmacol."},{"issue":"Suppl 1","key":"2095_CR25","first-page":"S2","volume":"60","author":"DN M\u00fcller","year":"2003","unstructured":"M\u00fcller DN, Fiebeler A, Park JK, Dechend R, Luft FC (2003) Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage. Clin Nephrol. 60(Suppl 1):S2\u2013S12","journal-title":"Clin Nephrol."},{"issue":"6 Pt 2","key":"2095_CR26","doi-asserted-by":"publisher","first-page":"83S","DOI":"10.1016\/S0895-7061(01)02074-X","volume":"14","author":"EL Schiffrin","year":"2001","unstructured":"Schiffrin EL (2001) Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens. 14(6 Pt 2):83S\u201389S","journal-title":"Am J Hypertens."}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-019-02095-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:27:23Z","timestamp":1588807643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-019-02095-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s11739-019-02095-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by our Institutional Board, since respecting human rights.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements on human and animal rights"}},{"value":"All patients gave informed consent to be enrolled in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}